全文获取类型
收费全文 | 1027篇 |
免费 | 99篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 56篇 |
妇产科学 | 10篇 |
基础医学 | 196篇 |
口腔科学 | 22篇 |
临床医学 | 145篇 |
内科学 | 241篇 |
皮肤病学 | 42篇 |
神经病学 | 40篇 |
特种医学 | 124篇 |
外科学 | 56篇 |
综合类 | 20篇 |
预防医学 | 71篇 |
眼科学 | 5篇 |
药学 | 48篇 |
肿瘤学 | 67篇 |
出版年
2022年 | 6篇 |
2021年 | 19篇 |
2020年 | 10篇 |
2019年 | 11篇 |
2018年 | 9篇 |
2017年 | 32篇 |
2016年 | 11篇 |
2015年 | 23篇 |
2014年 | 26篇 |
2013年 | 37篇 |
2012年 | 25篇 |
2011年 | 29篇 |
2010年 | 46篇 |
2009年 | 52篇 |
2008年 | 24篇 |
2007年 | 51篇 |
2006年 | 49篇 |
2005年 | 29篇 |
2004年 | 35篇 |
2003年 | 22篇 |
2002年 | 28篇 |
2001年 | 39篇 |
2000年 | 26篇 |
1999年 | 23篇 |
1998年 | 43篇 |
1997年 | 51篇 |
1996年 | 43篇 |
1995年 | 37篇 |
1994年 | 19篇 |
1993年 | 21篇 |
1992年 | 11篇 |
1991年 | 17篇 |
1990年 | 25篇 |
1989年 | 25篇 |
1988年 | 31篇 |
1987年 | 27篇 |
1986年 | 11篇 |
1985年 | 15篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 14篇 |
1981年 | 7篇 |
1980年 | 12篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1975年 | 5篇 |
1972年 | 5篇 |
1971年 | 6篇 |
1967年 | 4篇 |
排序方式: 共有1147条查询结果,搜索用时 9 毫秒
1.
Davies S. P.; Webb W. J. S.; Patou G.; Murray W. K.; Denning D. W. 《Nephrology, dialysis, transplantation》1987,2(6):568-572
The second documented case of renal aspergilloma due to Aspergillusflavus is presented. The merits of the medical therapy thatfailed are discussed. Pathological examination showed a nidusof aspergillus around suture material persisting from a pyelolithotomyoperation 2 years before in India. We argue that this was thereason for the failure of the medical therapy. This is the firstcase of its kind reported. 相似文献
2.
3.
4.
5.
Polycystic kidney disease is an autosomal dominant disease that may be associated with cystic disease of the liver. In women, the cysts may develop early and be more troublesome than in men. Cystadenocarcinoma of the pancreas is uncommon, comprising 1% of primary pancreatic malignancies. This case report is the first to describe a familial association between polycystic kidney disease and cystadenocarcinoma of the pancreas and liver in the English medical literature. A patient with autosomal dominant polycystic kidney disease (ADPKD) and multiple hepatic cysts developed cystadenocarcinoma of the pancreas with multiple malignant liver cysts. The patient's mother, sister, and niece had ADPKD, and the patient's sister also died of pancreatic cystadenocarcinoma. We believe that the development of these two disease entities in which the primary pathology is cyst formation has a genetic association. (Gastroenterology 1997 Jun;112(6):2104-7) 相似文献
6.
The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. 总被引:66,自引:15,他引:51
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
7.
Evaluation of a new enzyme-linked immunosorbent assay test for rotavirus antigen in faeces 总被引:6,自引:0,他引:6
下载免费PDF全文
![点击此处可从《Journal of clinical pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A new commercial test for the diagnosis of rotavirus gastroenteritis was assessed. With some modifications it compared favourably with electron microscopy and immunofluorescence. 相似文献
8.
H.?SambatakouEmail author M.?Guiver D.?Denning 《European journal of clinical microbiology & infectious diseases》2003,22(11):681-685
A 25-year-old male with chronic granulomatous disease developed severe bilateral pulmonary aspergillosis confirmed by a positive result of polymerase chain reaction for Aspergillus species from sputum and positive serological tests for Aspergillus. He was successfully treated with voriconazole. The diagnostic difficulties and the new therapeutic options in the era of new antifungal agents are discussed. 相似文献
9.
Abrams DI Bebchuk JD Denning ET Davey RT Fox L Lane HC Sampson J Verheggen R Zeh D Markowitz NP;Terry Beirn Community Programs for Clinical Research on AIDS 《Journal of acquired immune deficiency syndromes (1999)》2002,29(3):221-231
The effect of intermittent courses of recombinant interleukin-2 (rIL-2) on HIV-1 load in patients receiving combination antiretroviral therapy remains uncertain. CPCRA 059 was an open-label, randomized, multicenter trial in which 511 patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3 who were receiving antiretroviral therapy were assigned to receive no rIL-2 (255 patients [controls]) or subcutaneous rIL-2 in dosages of 4.5 MIU (130) or 7.5 MIU (126) twice daily for 5-day courses every 8 weeks to maintain CD4+ cell counts that were twice the baseline value or > or = 1,000/mm3. The primary objective of this study was to compare the effects of the two doses of rIL-2 and no rIL-2 on viral load and CD4+ cell counts over 12 months. There was no difference in the following viral load measurements between the rIL-2 treatment groups and the control treatment group: percentage of patients with viral loads of <50 copies/mL at 12 months (p =.55), time to viral load of > or = 50 copies/mL for patients who had baseline viral loads of <50 copies/mL (p =.35), and change in viral load from baseline for patients who had viral loads of > or = 50 copies/mL at baseline (p =.63). At each follow-up visit, the change in CD4+ cell count from baseline was significantly greater in the rIL-2 treatment groups than in the control treatment group, with a mean difference of 251/mm3 at month 12 (95% confidence interval, 207-295; p <.0001). No unanticipated adverse experiences were seen in this trial, to our knowledge the largest randomized evaluation of rIL-2 treatment conducted to date. 相似文献
10.